OVECX | VMVAX | OVECX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 9.091 | 17.355 | 52% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 48.1M | 30.9B | 0% |
Annual Yield % from dividends | 0.00 | 2.14 | - |
Returns for 1 year | 8.62 | 27.09 | 32% |
Returns for 3 years | -30.12 | 13.54 | -222% |
Returns for 5 years | -13.54 | 47.45 | -29% |
Returns for 10 years | -32.23 | 96.84 | -33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRLYX | 8.58 | 0.01 | +0.12% |
BNY Mellon Developed Markets RE Scs - Y | |||
TNXAX | 10.93 | -0.02 | -0.16% |
1290 Loomis Sayles Multi-Asset Income A | |||
GAONX | 20.09 | -0.16 | -0.79% |
JPMorgan Global Allocation R2 | |||
FRISX | 99.69 | -0.97 | -0.96% |
Franklin Rising Dividends R6 | |||
MWOIX | 67.59 | -0.83 | -1.21% |
MFS Global Growth I |